07:39 AM EST, 12/13/2024 (MT Newswires) -- Gilead Sciences' ( GILD ) investigational drug seladelpar received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for the treatment of primary biliary cholangitis, an autoimmune liver disease, the European regulator said Friday. In a statement, Gilead said the CHMP's recommendation was for seladelpar as treatment...

07:44 AM EST, 12/13/2024 (MT Newswires) -- Inovio Pharmaceuticals ( INO ) said Friday it has priced a public offering of 10 million shares and accompanying warrants to purchase the same number of shares at $3 per share and accompanying warrant. The warrants are exercisable at a price of $3.76 per share. Gross proceeds from the offering, which is expected...

07:55 AM EST, 12/13/2024 (MT Newswires) -- AGF Management (AGF-B.TO) on Friday declared a dividend of $0.115 per share on both the class B non-voting shares and the class A voting common shares of the company. The dividend will be payable on Jan. 16 to shareholders of record on Jan. 8, the company added. This latest dividend is unchanged from...

07:50 AM EST, 12/13/2024 (MT Newswires) -- Intel ( INTC ) executives said Thursday at an investment banking conference in San Francisco that it is possible to spin off the company's manufacturing business, depending on the success of a new chipmaking technology slated for next year, according to a conference transcript. When asked whether the success of the 18A technology...